Literature DB >> 10329553

Rotavirus-specific cytotoxic T lymphocytes recognize overlapping epitopes in the amino-terminal region of the VP7 glycoprotein.

J Buesa1, J V Raga, J Colomina, C O de Souza, C Muñoz, M T Gil.   

Abstract

Rotavirus-specific cytotoxic T lymphocytes (CTL) play an important role in the resolution of rotavirus infection. The outer capsid glycoprotein, VP7, elicits a class I MHC-restricted CTL response. Vaccinia virus recombinants expressing the VP7 genes from simian rotavirus SA11 (serotype G3) and from the RF strain of bovine rotavirus (serotype G6) were used to analyze the CTL activity to this antigen in BALB/c (H-2(d)) and C57BL/6 (H-2(b)) mice neonatally infected with homologous and heterologous rotaviruses. A vaccinia virus recombinant expressing the first amino-terminal 88 amino acids of VP7 was constructed and used to search for cross-reactive CTL against this region of the protein. By using synthetic Kb, Db, and Kd motif-fitting peptides two overlapping CTL epitopes have been identified located in the first hydrophobic domain (H1) of VP7. Splenocytes obtained from rotavirus SA11-infected C57BL/6 mice induced the strongest CTL response against target cells sensitized with a peptide containing a Kb-restricted CTL epitope (amino acids 8-16). A second Kd-restricted epitope (residues 5-13) was recognized by splenocytes derived from rotavirus-infected BALB/c mice. These findings reveal the existence of CTL epitopes in the H1 signal sequence of the VP7 glycoprotein that coexist with a CTL epitope (residues 31-40) previously described within the H2 region. Copyright 1999 Academic Press.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10329553     DOI: 10.1006/viro.1999.9646

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  7 in total

1.  Rotavirus VP7 epitope chimeric proteins elicit cross-immunoreactivity in guinea pigs.

Authors:  Bingxin Zhao; Xiaoxia Pan; Yumei Teng; Wenyue Xia; Jing Wang; Yuling Wen; Yuanding Chen
Journal:  Virol Sin       Date:  2015-10-10       Impact factor: 4.327

2.  Expression of human rotavirus chimeric fusion proteins from replicating but non disseminating adenovectors and elicitation of rotavirus-specific immune responses in mice.

Authors:  Aurélie Girard; Elodie Roques; Marie-Claude St-Louis; Bernard Massie; Denis Archambault
Journal:  Mol Biotechnol       Date:  2013-07       Impact factor: 2.695

3.  Characterization of homologous and heterologous rotavirus-specific T-cell responses in infant and adult mice.

Authors:  María C Jaimes; Ningguo Feng; Harry B Greenberg
Journal:  J Virol       Date:  2005-04       Impact factor: 5.103

4.  Growth of rotaviruses in primary pancreatic cells.

Authors:  Barbara S Coulson; Paul D Witterick; Yan Tan; Marilyn J Hewish; Joanne N Mountford; Leonard C Harrison; Margo C Honeyman
Journal:  J Virol       Date:  2002-09       Impact factor: 5.103

5.  Alteration of the thymic T cell repertoire by rotavirus infection is associated with delayed type 1 diabetes development in non-obese diabetic mice.

Authors:  Nicole L Webster; Christel Zufferey; Jessica A Pane; Barbara S Coulson
Journal:  PLoS One       Date:  2013-03-15       Impact factor: 3.240

6.  In silico study of rotavirus VP7 surface accessible conserved regions for antiviral drug/vaccine design.

Authors:  Ambarnil Ghosh; Shiladitya Chattopadhyay; Mamta Chawla-Sarkar; Papiya Nandy; Ashesh Nandy
Journal:  PLoS One       Date:  2012-07-26       Impact factor: 3.240

7.  Genome-Wide Evolutionary Analyses of G1P[8] Strains Isolated Before and After Rotavirus Vaccine Introduction.

Authors:  Mark Zeller; Celeste Donato; Nídia Sequeira Trovão; Daniel Cowley; Elisabeth Heylen; Nicole C Donker; John K McAllen; Asmik Akopov; Ewen F Kirkness; Philippe Lemey; Marc Van Ranst; Jelle Matthijnssens; Carl D Kirkwood
Journal:  Genome Biol Evol       Date:  2015-08-08       Impact factor: 3.416

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.